000			01647 a2200445 4500
005			20250514011930.0
264		0	_c20011204
008			200112s 0 0 eng d
022			_a0091-6749
024	7		_a10.1067/mai.2001.118598 _2doi
040			_aNLM _beng _cNLM
100	1		_aBoguniewicz, M
245	0	0	_aEffects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. _h[electronic resource]
260			_bThe Journal of allergy and clinical immunology _cOct 2001
300			_a651-2 p. _bdigital
500			_aPublication Type: Clinical Trial; Letter; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Topical
650	0	4	_aAdolescent
650	0	4	_aAdrenal Cortex Hormones _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAntigens, Bacterial
650	0	4	_aCefuroxime _xanalogs & derivatives
650	0	4	_aCephalosporins _xtherapeutic use
650	0	4	_aChild
650	0	4	_aDermatitis, Atopic _xprevention & control
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProdrugs _xtherapeutic use
650	0	4	_aStaphylococcal Skin Infections _xprevention & control
650	0	4	_aStaphylococcus aureus _xdrug effects
650	0	4	_aSuperantigens
700	1		_aSampson, H
700	1		_aLeung, S B
700	1		_aHarbeck, R
700	1		_aLeung, D Y
773	0		_tThe Journal of allergy and clinical immunology _gvol. 108 _gno. 4 _gp. 651-2
856	4	0	_uhttps://doi.org/10.1067/mai.2001.118598 _zAvailable from publisher's website
999			_c11510611 _d11510611